Analysts at StockNews.com assumed coverage on shares of Rubicon Technology (NASDAQ:RBCN – Get Rating) in a report released on Friday. The brokerage set a “sell” rating on the semiconductor company’s stock.
Rubicon Technology Stock Performance
RBCN stock opened at $1.74 on Friday. Rubicon Technology has a twelve month low of $1.26 and a twelve month high of $17.74. The company has a debt-to-equity ratio of 0.52, a quick ratio of 2.53 and a current ratio of 3.16. The stock’s 50 day moving average is $1.61 and its 200-day moving average is $2.91.
Institutional Trading of Rubicon Technology
A hedge fund recently bought a new stake in Rubicon Technology stock. Citadel Advisors LLC acquired a new stake in shares of Rubicon Technology, Inc. (NASDAQ:RBCN – Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 21,412 shares of the semiconductor company’s stock, valued at approximately $46,000. Citadel Advisors LLC owned 0.87% of Rubicon Technology as of its most recent filing with the Securities and Exchange Commission (SEC).
About Rubicon Technology
Rubicon Technology, Inc engages in the provision of monocrystalline sapphire for applications in optical and industrial systems. It operates through the following business segments: Sapphire and Pharmacy Business. The company was founded on February 7, 2001 and is headquartered in Bensenville, IL.
- Get a free copy of the StockNews.com research report on Rubicon Technology (RBCN)
- Hormel Hits 2-Year Low, And The Dip Gets Bought
- Here’s Why Ross Could Soon Be Hitting All Time Highs
- The Bottom Is In For Salesforce.com
- It’s Time For A Fresh Look At The Kroger Co.
- West Fraser’s Earnings Scream Timber, Outlook Says Buy
Receive News & Ratings for Rubicon Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rubicon Technology and related companies with MarketBeat.com's FREE daily email newsletter.